News

Ole Henrik Bang-Andreasen joins AVANT BIO as an Investment Analyst

Ole Henrik Bang-Andreasen joins AVANT BIO as an Investment Analyst having helped lead public investments in life sciences tools and technologies, diagnostics, medical devices, and other non-healthcare verticals at an investment firm. He started his career as an investor, with later roles as a sell-side analyst and a long/short healthcare investment analyst. At AVANT BIO he plays a role in investment research and strategy, thesis development, and European relations.

Ole earned his Bachelor of Science in Accounting and Finance at Northeastern University, and his Master of Science in Econometrics at Boston University and has held roles both in the US and Europe.

Follow Ole on LinkedIn